Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharma Mar Sa (PHMMF)

Pharma Mar Sa (PHMMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharma Mar Sa Avda. De los Reyes 1 Pol. Ind. La Mina Madrid U3 28770 ESP

www.pharmamar.com P: 34-91-846-6000

Description:

Pharma Mar SA is a biopharmaceutical company. It engaged in the discovery and development of marine-derived anticancer drugs. The company's product pipeline consists of PM1183, plitidepsin, and PM184 which are in clinical trial stage. It operates primarily in Germany, Italy, France, Switzerland, United Kingdom, Belgium and the United States. Pharma Mar SA is headquartered in Madrid, Spain.

Key Statistics

Overview:

Market Capitalization, $K 561,012
Enterprise Value, $K 444,272
Shares Outstanding, K 18,010
Annual Sales, $ 171,150 K
Annual Net Income, $ 1,230 K
Last Quarter Sales, $ 36,470 K
Last Quarter Net Income, $ 1,510 K
EBIT, $ 39,390 K
EBITDA, $ 45,610 K
60-Month Beta 0.16
% of Insider Shareholders 1.88%
% of Institutional Shareholders 0.00%
Float, K 17,671
% Float 98.12%
Short Volume Ratio 0.78

Growth:

1-Year Return -30.58%
3-Year Return -39.63%
5-Year Return -18.63%
5-Year Revenue Growth -10.87%
5-Year Earnings Growth 106.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/22/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/22/20

PHMMF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.72%
Debt/Equity 0.19
Price/Sales 3.60
Price/Cash Flow 8.30
Price/Book 2.15
Book Value/Share 12.46
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar